Sangamo Biosciences (SGMO) Stock Statistics & Valuation Metrics

Sangamo Biosciences has a market cap or net worth of $162.92M. The enterprise value is $124.20M.

Sangamo Biosciences has 301,709,470 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sangamo Biosciences’s return on equity (ROE) is -4.30 and return on invested capital (ROIC) is -172.58%.

The current PE Ratio of Sangamo Biosciences is ―. Sangamo Biosciences’s PEG ratio is ―.

In the last 12 months, Sangamo Biosciences had revenue of 57.80M and earned -97.94M in profits. Earnings per share was -0.49.

In the last 12 months, operating cash flow was -35.90M and capital expenditures -291.00K, giving a free cash flow of -36.19M billion.

Sangamo Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Sangamo Biosciences upcoming earnings date is Oct 30, 2025, After Close (Confirmed).

Sangamo Biosciences as a current ratio of 1.13, with Debt / Equity ratio of 119.69%

In the past 12 months, Sangamo Biosciences has paid -167.00K in taxes.

Sangamo Biosciences EV to EBITDA ratio is -2.18, with an EV/FCF ratio of -2.88.

Sangamo Biosciences has $38.34M in cash and marketable securities with $23.46M in debt, giving a net cash position of -$14.88M billion.

Gross margin is 97.40%, with operating margin of -179.88%, and net profit margin of -169.45%.

The average price target for Sangamo Biosciences is $4.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy